The metabolic syndrome is related to β3-adrenoceptor sensitivity in visceral adipose tissue
Authors:
- 1 July 1996
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 39 (7) , 838-860
Abstract
Summary The metabolic syndrome is a well-known risk for the development of cardiovascular disease. In the present study the possible importance of an altered visceral adipocyte β-adrenoceptor function in this syndrome was investigated. In 65 subjects of both sexes undergoing elective surgery for non-malignant disorders, the metabolic syndrome phenotype and the lipolytic sensitivity for various β-adrenoceptor subtype agonists in omental adipocytes were determined. The study group represented a wide range of abdominal adipose tissue distribution (waist-to-hip ratios 0.76-1.13), but was otherwise apparently healthy. The subjects were divided into three subgroups according to their waist-to-hip (WHR) ratios: 1) WHR < 0.92; 2) WHR 0.92-1.04; 3) WHR > 1.04. The subgroups demonstrated significant differences regarding body mass index, sagittal diameter, systolic and diastolic blood pressures, plasma concentrations of glucose, insulin, triglycerides and HDL-cholesterol (p = 0.005-0.0001). Furthermore, in omental adipocytes β3-adrenoceptor sensitivity, but not β1 and β2-adrenoceptor sensitivities, differed significantly between the WHR subgroups (p = 0.0001). β3-adrenoceptor sensitivity was also related to the other components of the metabolic syndrome, although a strong covariation between WHR and β3-adrenoceptor sensitivity vs blood pressure and the metabolic parameters was found. The present data provide evidence of a relationship between upper-body obesity and its associated metabolic complications and also, an increased visceral fat β3-adrenoceptor sensitivity. We suggest that the latter finding results in an augmented release of non-esterified fatty acids from the visceral fat depot to the portal venous system. This may in turn contribute to the development of the metabolic syndrome.Keywords
This publication has 10 references indexed in Scilit:
- Association of Trp64Arg mutation of the ?3-adrenergic-receptor with NIDDM and body weight gainDiabetologia, 1996
- A Mutation in the β3-Adrenergic Receptor Gene Is Associated with Obesity and Hyperinsulinemia in Japanese SubjectsBiochemical and Biophysical Research Communications, 1995
- Association of a Polymorphism in the β3-Adrenergic–Receptor Gene with Features of the Insulin Resistance Syndrome in FinnsNew England Journal of Medicine, 1995
- Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor GeneNew England Journal of Medicine, 1995
- Genetic Variation in the β3-Adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid ObesityNew England Journal of Medicine, 1995
- μ3-Adrenoceptor: an updateEuropean Journal of Endocrinology, 1995
- A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.Journal of Clinical Investigation, 1995
- Minireview: Mutations and Diseases of G Protein Coupled ReceptorsJournal of Receptors and Signal Transduction, 1995
- Genetics of ObesityAnnual Review of Nutrition, 1993
- Molecular Cloning and Expression of the Rat β3-Adrenergic ReceptorMolecular Pharmacology, 1991